Kolansky DM - Search Results

1

Treatment of familial hypercholesterolemia: is there a need beyond statin therapy?

Raper A, Kolansky DM, Cuchel M. Raper A, et al. Among authors: kolansky dm. Curr Atheroscler Rep. 2012 Feb;14(1):11-6. doi: 10.1007/s11883-011-0215-y. Curr Atheroscler Rep. 2012. PMID: 22135161 Review.

2

Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia.

Raper A, Kolansky DM, Sachais BS, Meagher EA, Baer AL, Cuchel M. Raper A, et al. Among authors: kolansky dm. J Clin Lipidol. 2015 Jan-Feb;9(1):107-12. doi: 10.1016/j.jacl.2014.08.005. Epub 2014 Aug 23. J Clin Lipidol. 2015. PMID: 25670368 Free PMC article.

3

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Cuchel M, et al. Among authors: kolansky dm. N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189. N Engl J Med. 2007. PMID: 17215532 Free article. Clinical Trial.

4

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.

Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, Araujo L, Vohra Y, Defesche JC, Wilson JM, Rader DJ. Kolansky DM, et al. Am J Cardiol. 2008 Dec 1;102(11):1438-43. doi: 10.1016/j.amjcard.2008.07.035. Epub 2008 Sep 11. Am J Cardiol. 2008. PMID: 19026292

5

Reconstituted high-density lipoprotein therapies: a cause for optimism.

Javaheri A, Kolansky DM, Cuchel M. Javaheri A, et al. Among authors: kolansky dm. Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1800-2. doi: 10.1161/ATVBAHA.114.304156. Arterioscler Thromb Vasc Biol. 2014. PMID: 25142879 Free PMC article. No abstract available.

6

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

Cuchel M, Meagher EA, du Toit Theron H, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessis AM, Propert KJ, Sasiela WJ, Bloedon LT, Rader DJ; Phase 3 HoFH Lomitapide Study investigators. Cuchel M, et al. Lancet. 2013 Jan 5;381(9860):40-6. doi: 10.1016/S0140-6736(12)61731-0. Epub 2012 Nov 2. Lancet. 2013. PMID: 23122768 Free PMC article. Clinical Trial.

7

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ 3rd, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE, et al. Grossman M, et al. Among authors: kolansky dm. Nat Med. 1995 Nov;1(11):1148-54. doi: 10.1038/nm1195-1148. Nat Med. 1995. PMID: 7584986 Clinical Trial.

8

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ 3rd, Kolansky DM, Muller DW, Wilson JM. Raper SE, et al. Among authors: kolansky dm. Ann Surg. 1996 Feb;223(2):116-26. doi: 10.1097/00000658-199602000-00002. Ann Surg. 1996. PMID: 8597504 Free PMC article. Clinical Trial.

9

Gene therapy for ischemic heart disease.

Malosky S, Kolansky DM. Malosky S, et al. Among authors: kolansky dm. Curr Opin Cardiol. 1996 Jul;11(4):361-8. doi: 10.1097/00001573-199607000-00004. Curr Opin Cardiol. 1996. PMID: 8879946 Review.

10

Evolution and Outcomes of Premature Coronary Artery Disease.

Smith CL, Seigerman M, Adusumalli S, Giri J, Fiorilli PN, Kolansky DM, Kobayashi T. Smith CL, et al. Among authors: kolansky dm. Curr Cardiol Rep. 2021 Mar 8;23(4):36. doi: 10.1007/s11886-021-01457-8. Curr Cardiol Rep. 2021. PMID: 33686513 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page